CNBC Halftime Report Final Trades: Seagate Technology, Dollar General & Progressive

– CNBC

– CNBC

Total
0
Shares
Related Posts
Read More

Abbott Announced Data at the American Diabetes Association Scientific Sessions Show Freestyle Libre 3 System Is First and Only 14-day Continuous Glucose Monitor System to Achieve a Mean Absolute Relative Difference of Less Than 8%

Abbott (NYSE: ABT) today announced late-breaking clinical data that demonstrate the FreeStyle Libre® 3 system has an overall mean absolute relative difference (MARD) of 7.9%,1 making it the first and only 14-day continuous glucose monitoring (CGM) system to achieve a sub-8% overall MARD.

ABT